R&D Altanova

South Plainfield, United States Founded: 1969 • Age: 57 yrs Acquired By Advantest
Specialty pharmacy services for chronic conditions are provided.

About R&D Altanova

R&D Altanova is a company based in South Plainfield (United States) founded in 1969, and was acquired by Advantest in October 2021. Specialty pharmacy services for chronic conditions are provided. Its chief executive, as recorded, is Seyed Paransun.

Company details

Provider of specialty pharmacy services for chronic conditions. It offers medication therapy management for complex conditions, including access to difficult-to-obtain medications and support with insurance authorization and billing. The company assists patients with financial guidance and support to manage medication costs. It also supplies necessary medical equipment and offers online prescription refills and patient support. The pharmacy focuses on personalized care and patient education to ensure optimal medication adherence and outcomes.

Key Metrics

Funding Insights of R&D Altanova

  • Total Rounds 2
  • Investors Count 3

All 2 funding rounds of RD Altanova with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Apr 2015Debt – Conventional––
Mar 2015Private Equity Round––
Valuation history

4 investors in total: 4 institutional.

Investors in R&D Altanova

R&D Altanova has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Advantest, MidCap Financial and Abacus Finance.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Abacus Finance is engaged in providing tailored credit solutions to lower-middle market companies.
abacusfinance.comNew York, United States
Private debt funds are managed across multiple sectors.
2008midcapfinancial.comBethesda, United States
Private equity investments are made in technology and healthcare sectors.
riversidepartners.comBoston, United States
Semiconductor test systems and solutions are manufactured and sold.
1954advantest.comTokyo, Japan
Premium access

Investor details for RD Altanova

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of R&D Altanova

78 people are tracked at R&D Altanova (8 in leadership, 70 in team).

NameRoleGroup
Seyed Paransun
CEO & PresidentLeadership
Yubing Wang
Sr. Director, Global Technology DevelopmentLeadership
Aamir Jamil
Chief Technology OfficerLeadership
Dan Turpuseema
Director of Substrate TechnologyLeadership
Bassam Asfoor
Vice President Of SalesLeadership
Jim Ferrell
Director Of Program ManagementLeadership
Syed Yezdan
Director Of EngineeringLeadership
Ngela Chang
Human Resources DirectorLeadership
Shilpan Patel
Planning EngineerTeam
Arsalan Mushtaq
Design EngineerTeam
Dayyan Ahmed
Design EngineerTeam
Anzal Imran
CAM EngineerTeam
Bilal Shoukat
Design EngineerTeam
Malak Majeed Ullah Khan
Quality Assurance Engineer at R&D AltanovaTeam
Glenn Dearing
Quality Engineering Manager (Assembly)Team
Omer Hayat
Design EngineerTeam
Sana Mahreen
CAM EngineerTeam
Taha Salim
Design EngineerTeam
Sabahat Rizvi
Design Support EngineerTeam
Sheikh Babar Tanveer
Substrate Design EngineerTeam

58 more people are available in the full profile.

Premium access

Complete people profiles for R&D Altanova

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of R&D Altanova

5 dated milestones of R&D Altanova across 52 years, from founding to its latest funding, stage changes and deals.

  1. Founded R&D Altanova is founded.
  2. Exit Acquired by Riverside Partners.
  3. Funding First funding round.
  4. Funding Latest funding round, Debt – Conventional,.
  5. Exit Acquired by Advantest.

Web traffic of R&D Altanova

The website of R&D Altanova (rdaltanova.com) receives about 1.8K visits a month.

  • Monthly visits
    1.8K

    ▲ 706.2% vs previous month

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about R&D Altanova

R&D Altanova was founded in 1969 and raised its 1st funding round 46 years after it was founded.

R&D Altanova is headquartered in South Plainfield, United States. It is registered at South Plainfield, New Jersey, United States.

Seyed Paransun is the CEO of R&D Altanova, as recorded in our data.

Provider of specialty pharmacy services for chronic conditions. It offers medication therapy management for complex conditions, including access to difficult-to-obtain medications and support with insurance authorization and billing. The company assists patients with financial guidance and support to manage medication costs. It also supplies necessary medical equipment and offers online prescription refills and patient support. The pharmacy focuses on personalized care and patient education to ensure optimal medication adherence and outcomes.

R&D Altanova has 4 investors. Key investors include Advantest, MidCap Financial, Abacus Finance, and Riverside Partners.

Yes. R&D Altanova was acquired by Advantest in October 2021.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available